Introduction
Preeclampsia, hypertension and proteinuria developing after the 20 th gestational week, affects 3-10% of pregnancies and causes >50,000 maternal deaths annually. 1 Preeclamptic women have higher Angiotensin II (Ang II) sensitivity than non-preeclamptic women. 2 Altered uteroplacental perfusion triggers events leading to endothelial and vascular smooth muscle cell dysfunction, increased vascular resistance, and increased blood pressure. The rat reduced uterine-perfusion pressure (RUPP) model mimics this state-of-affairs. 3 Placental villous deterioration promotes the release of tumor necrosis factor-a (TNF ) and reactive oxygen species. 4 TNF promotes hypertension and proteinuria. 5 Endothelial dysfunction, diminished NO, prostacyclin (PGI-2) and altered hyperpolarizing relaxing factor pathways contribute [6] [7] [8] , as do cytochrome P450 (CYP) dependent metabolites. 3 Epoxyeicosatrienoic acids (EETs) occur as four different regio-isomers (5,6-, 8,9-, 11,12-, and 14,15-EET) and are produced by the CYP epoxygenases from arachidonic acid (AA). These epoxy-compounds can be further metabolized by the soluble epoxide hydrolase to the corresponding dihydroxyeicosatrienoic acids (5,6-, 8,9-, 11,12-, and 14,15-DHET). 9 5,6-EET can be further metabolized to 5,6-epoxy-thromboxane (5,6-epTXA1) by cyclooxgenases and thromboxane synthase. 10 Preeclampsia is associated with increased urinary DHET excretion, indicating enhanced endogenous EET formation in the affected women. 11 EETs are main products of AA metabolism in placenta, fetal membranes, decidua, trophoblasts, and myometrium. 12, 13 Based on these findings, we tested the hypothesis that human preeclampsia is associated with increased intrauterine expression of CYP epoxygenases and enhanced circulating EET levels. We used pharmacological inhibition of CYP epoxygenases to prove the pathophysiological significance of enhanced EET biosynthesis in rat models of preeclampsia.
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Cell culture and functional assay

SGHPL-4 cells derived from primary human first trimester extravillous trophoblasts (EVT)
transfected with the early region of SV40, previously known as MC418 were a kind gift from Judith E. Cartwright, St George's University of London, UK. These cells show similar invasive capabilities to primary EVTs and retain features of normal EVTs. 15 The effect of 72 h U-46619 (Cayman Europe) on Epidermal Growth Factor (EGF) (Sigma-Aldrich) induced invasion and of 5,6 EET (Cayman Europe) on tube formation and first trimester placental outgrowth were determined and are described in detail in supplemental methods.
Western Blot, Immunohistochemistry, and high-performance liquid chromatography (HPLC)
Cells were processed for protein isolation by RIPA-buffer and 40 μg protein was boiled with
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The bioassay was described previously. 17 Briefly, neonatal rat cardiomyocytes were dissociated from minced ventricles from 1-2 day old Wistar rats and cultured as monolayers. Spontaneously beating cell clusters occurred after 5-7 days. The beating rates were determined for six to eight individual clusters before and after addition of substances. Whole cell patch-clamp electrophysiology was carried out as described before in detail. 18 Briefly, whole cell currents were recorded using an EPC-9 patch-clamp amplifier at voltage ramps between -100 to 100 mV.
For the activation of K Ca -currents the cells were dialyzed with CaCl 2 (0.5 mol/l). The inhibitor followed by Triplequad-Tandem-Mass-spectrometry as formerly described. 16 Bri ri ief ef efly ly l , 0. 0 0.5 5 5 ml ml ml plasma was hydrolyzed with sodium hydroxide. 
Animal model and Isometric contraction measurements
Local regulatory committees approved all animal studies according to American Physiological Society standards. All animal studies were performed in timed pregnant Sprague-Dawley rats (Harlan Sprague Dawley Inc). We used the RUPP model, which relies on the application of a constrictive silver clip (0.203 mm) to the aorta superior to the iliac bifurcation performed while ovarian collateral circulation to the uterus is reduced with restrictive clips (0.100 mm) to the bilateral uterine arcades at the ovarian end. 19 Rats were treated by MsPPOH (Cayman Chemicals) or SC58236 (Sigma Aldrich). We also processed the transgenic rat with preeclamptic phenotype (PE) described previously. 20 Rats were treated with MsPPOH (Cayman Chemicals) as indicated. The isometric contraction measurements have been described previously. 21 The bifurcation of the iliac artery into the main branch of the uterine artery was prepared from pregnant control rats (SD) and PE rats. Models and methods are described in detail in supplemental methods.
Statistical analysis
Data are presented as means ± SEM when normal distributed or median with interquartile range ovarian collateral circulation to the uterus is reduced with restrictive clips (0.100 mm) to the bi ila la ate te tera ral l ut ut ter er e i in ne ar arca cades at the ovarian end. 19 Rat ats s s w w were treated by y y Ms sPP PP PPO OH (Cayman C Che em emicals) or r SC SC C5 58 5823 23 36 6 (S (Sig ig gm ma ma A A Ald ld ldri ric ch ch) ). W W We e also o o p proc oc ce es esse se sed d th the e e t tr ransg sg ge en nic ic c r rat at w wi it ith h h pr pr ree e ecl clam am mp p ptic ph phen en enot ot otyp yp ype e e (P (P (PE) E) ) d d des es escr cr ri ib ibed ed ed pre re evi vi v ou ou ousl sl sly. y. 2 20 20 R R Rat at ats s s we we were re re t tre re reat at ated ed d w w wit ith h h M Ms MsP P PPO PO POH H (C (C ( ay ay ayma ma man n n Ch Ch Chem em emic ic ica al als) s) s) a as ndicated. T The he he i i iso so some me metr tr ric ic c con on ontr tr trac c cti ti tion on on m m mea ea easu su sur rem em men en ents ts s h h hav ave e e be be been en en d d des es e cr cr rib ib ibed ed ed p p pre re revi viou ou ousl sl sly. y. y. 21 
Results
Uteroplacental and circulating dysregulation
We examined uteroplacental tissue of 25 preeclamptic and 23 women with uneventful pregnancies in microarray studies. Of 58 CYP genes represented on Illumina chips, solely 7
genes in decidual tissue and 3 in placental tissue respectively were up-or down-regulated more than 1.3-fold in the preeclamptic group as compared to control group. Of these genes, only CYP2J2 was significantly upregulated in both tissues. We confirmed this finding by real-time RT-PCR (Fig. 1A) . The CYP2J2 mRNA was significantly upregulated by a factor of 3.9 S1 ). We then localized the CYP2J2 protein in placental villous and decidual tissue by immunohistochemistry (Fig. 1B) . In both placental compartments, collected at term of gestation, we detected a strong co-localisation of CYP2J2 to the trophoblast marker cytokeratin 7 (CK7). The CYP2J2 staining was positive for cytotrophoblasts of the placental villous and extravillous trophoblasts of the decidua. The trophoblasts of placental villous and decidual tissue were also positive for CYP2J2 at week 12 of gestation ( Fig. 1B lower han 1.3-fold in the preeclamptic group as compared to control group. Of these ge ge ene e es, , o o onl nl nly y y CYP2J2 was significantly upregulated in both tissues. We confirmed this finding by real-time Fi Fig g g. 1 1A A A) ). ). The CYP2J2 mRNA was sig g gn ni n f f ficantly upregu u ula l te We were interested in the consequences of the uteroplacental CYP2J2 upregualtion in preeclampsia on circulating metabolites in the maternal circulation. We therefore analyzed the metabolites of the CYP2J2 in plasma of a longitudinal study population, comparing preeclamptic women to women with uneventful pregnancies (Fig. 1C) . The 5,6-(EET+DHET) concentrations were increased in pregnancy and subsequently decreased after birth. Beginning with the first trimester of pregnancy, we detected higher levels of the 5,6-and 14,15-eicosanoids in the preeclamptic circulation. These increases were significant during the second and third trimester.
RT RT-P -P -PCR CR CR ( ( (Fi
One day after delivery, the 5,6-(EET+DHET) levels were still significantly elevated in the preeclamptic samples as compared to controls. However, the levels of 14,15-(EET+DHET) were no longer statistically significant elevated. As the level of 11,12-and 8, 9-EET's and -DHET's
were not elevated in preeclamptic plasma compared to control plasma, the level of total EET and DHET were not elevated. Circulating levels of total EET and DHET's increased during pregnancy (data not shown) when 1 st and 3 rd trimester were compared. The CYP-hydroxylase metabolite 20-HETE levels were not dysregulated. The 5,6-EET/DHET-ratios were significantly lower in the 2 nd trimester in the preeclamptic group compared to the control group. In 3 rd trimester and post delivery the lowered ratios failed to show statistically significance. The ratios of all other metabolites were not statistically significant changed (Supplemental Fig. S2 ).
Regulation of CYP2J2
To elucidate the regulation of the CYP2J2, we screened for an obvious genetic influence and performed a SNP analysis, focusing on regulatory elements in CYP2J2. The genotypes of the SNPs located in the area upstream of the CYP2J2 gene were determined for the preeclamptic and control subjects by sequencing ( Table 1) . Altogether seven SNPs were found, including one preeclamptic samples as compared to controls. However, the levels of 14,15-(EE ET+ T+ T+DH DH HET ET ET) ) ) we we w re no longer statistically significant elevated. As the level of 11,12-and 8, 9-EET's and -DHET's we were re re n n not ot ot e e ele le lev previously unknown SNP. When Hardy-Weinberg equilibrium was tested in control subjects, the genotype frequencies for all except one SNP were in equilibrium. We tested for association between the SNPs and preeclampsia but found none. We could therefore not identify polymorphisms to account for the altered transcriptional expression level of the CYP2J2 gene in preeclampsia.
We next analyzed the regulation of CYP2J2 expression in trophoblast cells. The human first trimester trophoblast derived cell line SGHPL-4 was treated by different protocols, reflecting the preeclamptic situation. Ang II (10 -7 M) and hypoxic conditions (3% oxygen) did not alter the expression of CYP2J2 at several time points (data not shown). However, TNF , which is elevated in preeclampsia, 4, 22 stimulated the upregulation of CYP2J2 expression in SGHPL-4 cells (Fig. 2) . On mRNA level, the expression was significantly upregulated dose (5-10 ng/ml) and time dependent (6-120 h), reflecting an acute and a chronic inflammation. We confirmed this finding by Western blotting with 5 and 10 ng/ml TNF for 48 h (Fig. 2B ).
CYP2J2-metabolite Function
CYP2J2 activity leads to metabolite formation, including the 5,6-EET. 23 Exclusively, 5,6-EET can be further metabolized by the cyclooxygenases (COX) 1 and 2 and by thromboxane A synthase (TXS) to an thromboxane analog, the 5,6-epoxy-thromboxane A1 (5,6-epTXA1) 10 This thromboxane analog can induce signaling via the thromboxane receptor (Fig. 3A) . To study the functional capabilities of CYP2J2 metabolites, we used a cardiomyocyte contraction bioassay.
The model stems from our original observation that agents in preeclampsia could be identified by this model. 17, 24 We found that the metabolites had a chronotropic influence on the neonatal cardiomyocyte beating rate (Fig. 3B) . The metabolite 5,6-EET (30 nM) increased the spontaneous beating rate by 24 beats per minute (p<0.01) compared to control. This effect was which is elevated in preeclampsia, 4, 22 stimulated the upregulation of CYP2J2 exp xp pre e ess s io io ion n n in in in SGHPL-4 cells (Fig. 2) . On mRNA level, the expression was significantly upregulated dose (5-10 0 n n ng/ g/ g/ml ml ml) ) ) an an a d d d ti ime me me dependent (6-120 h), reflecti i ing n n an acute and a a a chro ro oni ni nic c inflammation. We Importantly, the inhibitory effect of 5,6-EET on K Ca 1.1 channel activity was completely prevented by preincubating the VSMCs with the thromboxane synthase inhibitor Furegrelate (Fig. 3C) . We further investigated the tube formation of the trophoblast-derived cell line SGHPL-4 in a Matrigel assay. The process of tube formation was enhanced by 5,6 EET.
Migration of trophoblasts from first trimester villous explants was unaffected by 5,6 EET (supplemental figure S3) . In a fibrin gel invasion assay, the invasive process was strongly induced by epidermal growth factor (EGF) and this effect was reduced by co-stimulation with the thromboxane analog U-46619 (Supplemental Fig. S4 ).
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We next used the RUPP model to test the role of CYP epoxygenases in preeclampsia development under in vivo conditions. 19 The CYP epoxygenase inhibitor MsPPOH ameliorated the preeclamptic syndrome in the RUPP rats. The mean arterial pressure (MAP) measured on day 18 of pregnancies was normalized by MsPPOH administration from 126 mm Hg in RUPP to 111 mm Hg in the MsPPOH-RUPP group (Fig 4A) . Similar to Zhou et al, we observed that
MsPPOH treatment in normal pregnant rats elevated MAP. 25 Normal pregnant rats had a MAP of 101 mm Hg and MsPPOH treatment increased MAP to 110 mm Hg. MsPPOH also improved the RUPP-related pregnancy outcomes. We found that the pup weight was partially restored by the treatment, compared to controls (Fig. 4A) . The cyclooxygenase (COX) inhibitor SC58236 also improved the preeclamptic features in RUPP rats. The MAP was lowered to 115 mm Hg and the pup weight increased to 2 g in RUPP+SC58236 group. The 5,6-(EET+DHET) levels were enhanced in RUPP rats compared to controls and were decreased to control levels after MsPPOH administration (p<0.01) (Fig 4B) . All other metabolites (8,9-, 11,12-, 14,15-EET+DHETs) were not statistically significant elevated in RUPP rats, although a trend towards elevation was observable. However, levels of 11,12-and 14,15-(EET+DHET) significantly decreased after MsPPOH treatment. The RUPP procedure and the MsPPOH treatment did not statistically significant affect the CYP hydroxylase metabolite 20-HETE, the linoleic acid epoxymetabolites 9,10-and 12,13-(EpOME+DiHOME), and the EET/DHET-ratios (Supplemental Fig. S5 and   S6 ).
We then performed experiments in a transgenic preeclamptic rat model (PE) that we developed earlier, which features hypertension and albuminuria from day 13 of pregnancy onwards. 20, 21 In this model 5,6-(EET+DHET) levels were elevated compared to normal pregnant Sprague Dawley rats (SD), whereas other metabolites (8,9-, 11,12-, 14,15-EET+DHETs) and mproved the preeclamptic features in RUPP rats. The MAP was lowered to 115 5 m mm m m Hg Hg Hg a a and nd nd t th he pup weight increased to 2 g in RUPP+SC58236 group. The 5,6-(EET+DHET) levels were en nha ha hanc nc nc d ed ed i i in n n RU R RUPP PP PP r rats compared to controls an nd d d w w were decreased d t t to co co ont nt ntr rol levels after MsPPOH ad dm mi ministration n ( ( (p< p< p<0.01 01 0 ) ) ( ( (Fi Fi Fig g g 4B 4 4B ). ) A A All l o ot th her m m metab b bo ol lite es es ( (8, 8,9-9-9 , , 11 11 1,1 12-2 , 14 14 1 ,1 ,15-5--E E EET ET T+D +D +DHE HE H Ts Ts Ts) ) w we were no not t t st st tat at atis isti tica ca call l lly y s s sign gn gnif ifi ica an ant t el el lev ev e at at ated ed ed i in n RU RU UPP PP PP r r rat at a s, s, s, a al lt f f f f h ho houg ug ugh h h a a tr tr tren en nd d d to to tow w war rd rds s el el e ev ev e at at tio io on wa wa was s EET/DHET-ratios were not statistically significant dysregulated (Supplemental Fig. S7 ).
MsPPOH treatment in these rats lowered the MAP and the albuminuria significantly ( Fig. 4C and 4D). As we reported in our earlier study 21 , uterine artery rings from these hypertensive dams showed a pronounced relaxation to low doses of acetylcholine (Ach) (1x10 -9 to 1x10 -6 mol/L) and a paradoxical contractile response to higher doses (3x10 -6 to 1x10 -5 mol/L), compared to rings from SD. This effect of paradoxical contractile response was diminished when the thromboxane receptor antagonist SQ29548 and the cyclooxygenase inhibitor indomethacin was applied. Here we found that the expression of thromboxane A synthase 1 (TBXAS1) and cyclooxygenase 1 (COX1) was upregulated in these arteries (Supplemental Fig. S8 ).
Furthermore, we found that MsPPOH also abolished the contractile response to Ach with doses above 3x10 -6 mol/L in both, the PE and the SD group (Fig. 4E) . Expression of TBXAS1, COX1
and COX2 were also upregulated in placenta of PE-rats. In addition, we detected the 5,6-epoxythromboxane with two characteristic transitions of 385.2 -229.2 and 385.2 -167 (Supplemental Fig. S9 ).
Discussion
Our results suggest a novel link between CYP-eicosanoids and preeclampsia. We found that CYP2J2 expression was significantly up-regulated in the uteroplacental unit of preeclamptic women compared to women with uncomplicated pregnancies. The CYP2J2 protein was specifically localized to the trophoblasts in these uteroplacental tissues. Our LC-MS/MS analysis revealed that the development of preeclampsia is associated with increased circulating levels of these metabolites and of 5,6-EET+DHET, in particular, even before clinical onset of the syndrome. In trophoblasts, we identified the pro-inflammatory cytokine TNF as a potent Furthermore, we found that MsPPOH also abolished the contractile response to A Ac Ach h h wi wi with th th d d dos os o es e above 3x10 -6 mol/L in both, the PE and the SD group (Fig. 4E) . Expression of TBXAS1, COX1
an nd d d CO CO COX2 X2 X2 w we ere e al al also so upregulated in placenta of f P P PE E--rats. In additio io on, w w we e e d detected the 5,6-epoxyf f h h hro o omb m oxane wi wi ith th t two wo o c c cha ha hara ra ract ct cter eris is st t tic ic c t tra ran nsiti i ion n ns o of 3 385 5 5. Most of these novel findings may come as a surprise, when compared to previous studies demonstrating exclusively beneficial roles of EETs in the regulation of cardiovascular and renal function. EETs mediate vasodilatation and are generally considered as anti-hypertensive metabolites. [27] [28] [29] [30] [31] Normal pregnancy results in enhanced EET formation and pharmacological inhibition of CYP epoxygenases causes hypertension and renal failure in pregnant rats. 25, 32 Moreover, EETs exert anti-inflammatory and anti-apoptotic effects that contribute to tissue protection under hypoxic conditions. 28 Prominent examples include EET-mediated protection against ischemia-reperfusion injury in the heart and brain. 33, 34 Exogenous EET administration and/or CYP2J2 overexpression also prevent cytokine-induced activation as well as hypoxiainduced damage of endothelial cells. Most of of f t t the he ese e n n nov ov vel el el f f fin in indi ding ng ngs s s m ma may y y co om m me as s a a su urp rp rpri ris se e, wh wh hen n n c com om mp pa pare re ed d d to to p p pre re r vi vi vio o ous s s st stud ud udi ies de demo mo mons ns n tr trat at tin in ing g ex ex xc cl lus usi iv ive el ely y be be ene ne efi fi fici ci cial a al r rol ol o es es es o o of EE EE E T Ts Ts i in n th h he e e r re regu gu gula la ati t on on on o of f f c ca ard rd dio io i va va v sc sc cu ul ular r an nd nd r r ren enal a function. EE ETs Ts Ts m m med ed edia iate te te vas as asod od odil lat at atat at a io io ion an an and d d ar ar are e e ge ge gene ne nera ra r lly y y co co cons ns n id id ider er ered d d a a as s s an an anti ti ti-h -hyp yp yper er erte te tens ns nsiv i e ameliorate the preeclamptic syndrome. However, our findings are apparently contradictory to this notion. Indicating that the role of EETs has to be specifically defined for the given pathophysiological condition, we found that pharmacological CYP-epoxygenase inhibition indeed raises blood pressure in normal rat pregnancy but exerts the opposite effect in the RUPP model and the transgenic model of preeclampsia. Furthermore, our study shows that trophoblasts are an additional site of EET production and the major site of the uteroplacental unit, where the EET-producing CYP2J2 is up-regulated during preeclampsia.
A major difference between normal and preeclamptic pregnancy concerns the sites and mechanisms of enhanced EET biosynthesis. In normal pregnancy, increased EET biosynthesis occurs in the kidney and vasculature, 25, 32 where EETs promote antihypertensive and antiinflammatory mechanisms. In contrast, our study shows that uteroplacental trophoblasts are the major site of EET-producing CYP2J2, which is upregulated during preeclampsia. Although limited in scale, our genetic analysis indicates that common polymorphisms in the CYP2J2 promoter do not contribute to preeclampsia susceptibility. However, we found that CYP2J2 is highly inducible by TNF in cultured trophoblasts. This finding suggests that CYP2J2 overexpression proceeds secondary to enhanced TNF release in response to placental ischemia.
Trophoblasts are key players in spiral artery remodeling; a failure in this process may cause preeclampsia. 37 Trophoblast invasion is triggered by hypoxia but surprisingly repressed after activation of the hypoxia-inducible factor HIF-1 . 38 Providing a possible link between CYP2J2/EET expression and trophoblast invasion, EETs activate HIF-1 as shown in other cell types. 39 In accordance with their vasculoprotective properties 40 , EETs may also prevent the replacement of endothelial cells for trophoblasts during spiral artery remodeling.
A link between enhanced EET biosynthesis and preeclampsia is suggested by the occurs in the kidney and vasculature, 25, 32 where EETs promote antihypertensive e a and nd d antiinflammatory mechanisms. In contrast, our study shows that uteroplacental trophoblasts are h he e ma ma majo jo jor r si si site te te of f E EE EET-producing CYP2J2, which h h is is upregulated d dur u u in ng g g p pr preeclampsia. Although pregnancies, we observed no differences in the plasma levels of 8,9-and 11,12-EET. However, we found a pronounced increase of the 5,6-and 14,15-EET levels. Noteworthy, 5,6-EET has been identified as the predominant EET regioisomer in trophoblasts and other intrauterine tissues. 13 5,6-EET is also the major product of cAMP-induced AA metabolism in human first trimester trophoblasts. 41 Moreover, CYP2J2 is probably unique among the human epoxygenases in generating the whole set of regioisomeric epoxides including 5,6-EET. 23 Accordingly, the increased circulating EET levels in preeclampsia may indeed reflect enhanced CYP2J2-mediated uteroplacental EET biosynthesis.
In general, the beneficial cardiovascular effects of EETs have been attributed to the whole class of these AA metabolites. However, most of the biological activities are certainly regio-and stereoselective. Importantly, the effects of 5,6-EET can be modified by subsequent metabolism.
Unlike other EET regio-isomers, 5,6-EET is readily metabolized by cyclooxygenases and can be converted into a potent vasoconstrictor by the subsequent action of thromboxane synthase. 10 Given the imbalance of PGI2 and TXA2 in preeclampsia, thromboxane-analog formation may be an important source of thromboxane synthesis during the development of the syndrome.
In preeclampsia, endothelial dysfunction or inappropriate cell activation, as well as alterations in endothelium-dependent vascular contractile properties, is part of the maternal syndrome. In an earlier study, we had shown that the vasodilatory response is reduced in the uterine artery of our PE rats. Uterine artery rings from PE rats relaxed at low acetylcholine doses, whereas higher doses increase the resistance. Our data suggested that a cyclooxygenasedependent, thromboxane-like metabolite is responsible. 21 Now we could further show that the paradoxical acetylcholine response is also prevented by MsPPOH. This finding indicates that a
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CYP epoxygenase dependent metabolite served as precursor of the thromboxane-like activity.
This observation is in line with observations in humans. In vitro studies on isolated microvessels from patients with preeclampsia showed an absence of ACh-mediated vasodilatation in omental micro-vessels. 42 Thus, our data direct attention to possibly similar mechanisms in preeclampsia.
Ang II is a strong vasoactive peptide. During normal pregnancies, the Ang II responsiveness is reduced, compared to the non-pregnant state. However, in preeclampsia the Ang II sensitivity is elevated. 2 In recent studies, we described an elevated Ang II sensitivity mediated by agonistic autoantibodies to the Ang II-receptor type 1. 43 Here, we demonstrated that 5,6-EET also has a synergistic effect on the contractility of cardiomyocytes and could therefore be a potent facilitator of the Ang II sensitivity in preeclampsia.
Ca2+-activated K+-channels (KCa) modulate the membrane potential and regulate Ca2+-dependent contraction, and are therefore important mediators in the control of vascular tone and blood pressure. They induce membrane hyperpolarization in response to increased intracellular Ca 2+ and thereby counteract smooth muscle contractility. KCa1.1 channels, also known as the BK channels, are the predominantly expressed KCa channels in contractile VSMC and are the presumed targets of CYP-generated AA metabolites. 44, 45 KCa1.1-deficient mice with targeted disruption of -and -subunit genes show a phenotype consisting of hypertension and endothelial dysfunction. The relevance of K Ca 1.1 for blood pressure and cardiovascular disease has been also demonstrated by SNP-analysis. 44 We showed that 5,6-EET led to a down regulation of K Ca 1.1 channel activity, which was blocked by inhibiting the thromboxane synthase. These results suggest that the effects of EET are mediated by a thromboxane analog, such as the 5,6-epTXA1. Our data agree with the idea that blockade of Ca
2+
-activated K + channels can cause inhibition of endothelium-dependent hyperpolarizing factor (EDHF) and thus be a potent facilitator of the Ang II sensitivity in preeclampsia.
Ca2+-activated K+-channels (KCa) modulate the membrane potential and regulate Ca2+-de epe pe pend nd nden ent t t co co c n ntra ra act ct ctio ion, and are therefore importan an ant m mediators in t the h h co ont nt ntr r rol of vascular tone and b bl loo o od d pressure e. Th Th They y i ind nd duc uc ce e me m memb mb mbr ra ran n ne h hyp per r rpola a ar ri izat t tio io on n in in i r res espo po pons nse e to to inc nc cre re eas ased ed ed i i int nt n r r race ce cell llu ul u a a ar Ca Ca 2+ 2+ a a and nd n t the he her re reby by y c c cou oun n nte er erac act sm sm smoo oo ooth th th m m mus us uscl cl cle e e co o ont nt n ra r rac ct ctil li it i y. y. y K K KCa Ca Ca1. 1.1 1 ch ch chan an nne e els ls, al al a so so s k k kno no nown wn n a a as s th th he e BK channels, s, a a are re r t t the he he p p pre re redo o omi mi mina a ant nt ntly ly y e exp xp xpre re ress ss sed ed ed K K KC C Ca a ch ch c an an anne ne nels ls ls i i in n n co co c nt nt n ra ra ract ct ctil il ile e e VS VS SMC MC MC a a and n n are the 18 contribute to the increase of peripheral vascular resistance. The suggestion that EDHF contributes to vasodilatatory mechanisms during pregnancy is consistent with this notion.
We propose that uteroplacental CYP2J2 overexpression contributes to preeclampsia. Our data are consistent with the two-stage theory. 46 In stage 
B) B)
C CYP YP2J 2J2 2 (g (g ( re reen en) ) wa was s st stro rong ngly ly c co-o lo loca cali lize zed d to to t the he t tro roph phob ob bla last st m mar arke ke k r r cy cyto toke ke k ra rati tin n 7 7 (C (CK7 K7) ) Activation of the K Ca 1.1 current in the whole cell mode by 0.5 μM Ca 2+ led to a maximal current metabolized by the enzyme CYP2J2 to its epoxyeicosatrienoic acids (EET's) and nd d b by y y th th the e so solu lu lubl ble e epoxide hydrolase (sEH) to the dihydroxyeicosatrienoic acids (DHET's). MsPPOH inhibits cy yto to toch ch chr rome me me P P P45 50 0 0 e ep epoxygenases. 5,6-EET can be be m m metabolized by y th th t e cy cy yc cl clooxygenases 1 and 2 C CO OX OX1, COX X2) 2) an nd nd t the he h t thr h hrom om ombo boxa xa xan ne ne sy y ynth has ase (TX TX TXS) t t to o o th th he th thro ro om mb mbox x xan an ne e a an anal alog og 5 5,6 ,6 , -e -e epo po oxy xyh hro ro omb mb mbox ox oxan an ane e e A1 A1 1 ( (5, 5, 5 6-6-6-ep ep pTX TXA A1 A1) ) ) th th that a at c ca an an i i ind nd nduce ce ce s s sig ign na nali li ling ng ng v v via a t t the he e t thr hr hrom om mbo bo oxa xa ane ne ne r r rec ec ece ep epto to or. o litters of NP-group (n=5-9; * p<0.05; † p<0.001 ANOVA with Dunnett-T3; m m me ea ean n n S S SEM EM EM). ).
Furegrelate (T (T (TXS XS XS-I -I -
B) Cytochrome P450-metabolites are increased in RUPP-rats. This effect is lowered by
Ms Ms sPP PP PPO OH a adm dm dmin nis istr tra ation (n ( =5-9; ; * p< p 0.01 ANO NOVA VA VA with Dunnet et tt-t-t T3 3; ; me mean SEM). C) ) MAP m me m a a asured by tele e em m metry y y w w was en en enha hanc ced ed i in n tran n nsg g geni i ic rat ts s wi wi wit th th p pre eec eclamp p pti ic c p ph phe enoty y ype e e (P (PE E E) co comp mp par ar ared ed ed t t to o no no orm rm rmal al al p p pre re regn gn gnan nt t ra ra rats ts ts ( ( (SD SD). ). ) M M MsP sP sPPO PO POH H H ad ad admi mi mini ni nist st stra ra rati ti tion n n a a abo bo boli li lish sh shed ed e th th this is is e e eff ff ffec ect t t (n (n (n=4 =4 =4-6 -6 6; ; ; * * * 
Primer and Probes
Primer and probes were designed with PrimerExpress 3.0 (Applied Biosystems): 
Cell culture and functional assay
Invasion assay was processed with SGHPL-4 cells in 0.5% serum-reduced medium in fibrin gel as previously described protocol. 1 For this purpose, the cells were stained by CellTracker Green CMFDA (Invitrogen) and grown on gelatin coated microcarrier beads 
High-performance liquid chromatography (HPLC)
For preparing 5,6-epTXB1 and the corresponding 5,6-diol from TXB2 we followed a described procedure. through gestation day 19, when the animals were sacrificed. We also processed the transgenic rat with preeclamptic phenotype (PE) described previously. 5 Female Rats, harboring the human Angiotensinogen gene were mated by male rats, harboring the human renin gene. On day 11-12 of pregnancy, the blood pressure of these rats raised, measured by telemetric blood pressure measurements. PE rats were treated by 20 mg/kg/day MsPPOH (Cayman Chemicals) from day 12 on as indicated.
Isometric contraction measurements
The isometric contraction measurements were proceed on uterine arteries rings of Sprague-Dawley rats, transgenic for the human angiotensinogen (hAogen) gene, were crossed with male rats transgenic for the human renin (hRen) gene. During pregnancy, this model produces preeclampsia in the dams. Uterine arteries were excised and dissected into 2-mm rings. Each ring was dispensed between 2 stainless-steel wires and connected to a force transducer (Small Vessel Myograph, DMT 610 mol/l, Danish Myo Technology). A standard pretension was applied to the vessels after equilibration using the software Power-Lab Chart5 (ADInstruments). After equilibration, the arteries were exposed to isomolar 60 mmol/L of KCl-containing solution. Rings were stepwise preconstricted with 10 nM -10 µM Phenylephrine (Phe), exposed to MsPPOH (50µM) and endothelial function was assessed with increasing doses (10 nM -10 µM) of Acetylcholine (ACh).
Statistical analysis
For SNP-analysis, the evaluation of the Hardy-Weinberg equilibrium (HWE) was performed using an exact test in the PLINK software (MS-DOS -version v1.07). 6 Association of the SNPs with preeclampsia was tested using Fisher's exact test in the PLINK software. For each SNP, p-value of the test and estimated odds ratio for minor allele are reported.
Haploblocks (data not shown) were determined using Haploview software. In all studies, a value of p<0.05 was considered to be significant.
Supplemental Tables
Supplemental Table 1 Clinical characteristics of the preeclamptic cases and controls from the Oslo study population. Data are presented as mean ± standard deviation, BMI and Gestational weeks at delivery are presented as median (interquartile range). BMI: body mass index.
Supplemental Table 2 . Clinical characteristics of Longitudinal subjects
